Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 843

1.

Diurnal Harvest Cycle and Sap Composition Affect Under-Skin Browning in 'Honey Gold' Mango Fruit.

San AT, Hofman PJ, Joyce DC, Macnish AJ, Marques JR, Webb RI, Li G, Smyth HE.

Front Plant Sci. 2019 Sep 13;10:1093. doi: 10.3389/fpls.2019.01093. eCollection 2019.

PMID:
31608078
2.

Correction: The Naturally Processed CD95L Elicits a c-Yes/Calcium/PI3K-Driven Cell Migration Pathway.

Tauzin S, Chaigne-Delalande B, Selva E, Khadra N, Daburon S, Contin-Bordes C, Blanco P, Le Seyec J, Ducret T, Counillon L, Moreau JF, Hofman P, Vacher P, Legembre P.

PLoS Biol. 2019 Oct 8;17(10):e3000521. doi: 10.1371/journal.pbio.3000521. eCollection 2019 Oct.

3.

The association of PD-L1 expression with the efficacy of anti-PD-1/PD-L1 immunotherapy and survival of non-small cell lung cancer patients: a meta-analysis of randomized controlled trials.

Xu Y, Wan B, Chen X, Zhan P, Zhao Y, Zhang T, Liu H, Afzal MZ, Dermime S, Hochwald SN, Hofman P, Borghaei H, Lin D, Lv T, Song Y; written on behalf of AME Lung Cancer Collaborative Group.

Transl Lung Cancer Res. 2019 Aug;8(4):413-428. doi: 10.21037/tlcr.2019.08.09.

4.

Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France).

Heeke S, Benzaquen J, Hofman V, Ilié M, Allegra M, Long-Mira E, Lassalle S, Tanga V, Salacroup C, Bonnetaud C, Fayada J, Gazoppi L, Ribeyre L, Castelnau O, Garnier G, Cattet F, Nanni I, de Fraipont F, Cohen C, Berthet JP, Leroy S, Poudenx M, Marquette CH, Denis MG, Barlesi F, Hofman P.

Clin Lung Cancer. 2019 Aug 3. pii: S1525-7304(19)30214-1. doi: 10.1016/j.cllc.2019.07.010. [Epub ahead of print]

PMID:
31519454
5.

Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective.

Collett-Solberg PF, Ambler G, Backeljauw PF, Bidlingmaier M, Biller BMK, Boguszewski MCS, Cheung PT, Choong CSY, Cohen LE, Cohen P, Dauber A, Deal CL, Gong C, Hasegawa Y, Hoffman AR, Hofman PL, Horikawa R, Jorge AAL, Juul A, Kamenický P, Khadilkar V, Kopchick JJ, Kriström B, Lopes MLA, Luo X, Miller BS, Misra M, Netchine I, Radovick S, Ranke MB, Rogol AD, Rosenfeld RG, Saenger P, Wit JM, Woelfle J.

Horm Res Paediatr. 2019 Sep 12:1-14. doi: 10.1159/000502231. [Epub ahead of print]

6.

EGFR Mutation Analysis in Non-small Cell Lung Carcinoma from Tissue Samples Using the Fully Automated Idylla™ qPCR System.

Heeke S, Hofman P.

Methods Mol Biol. 2019;2054:147-155. doi: 10.1007/978-1-4939-9769-5_10.

PMID:
31482454
7.

In-house Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-small Cell Lung Cancer and Melanoma Patients.

Heeke S, Benzaquen J, Long-Mira E, Audelan B, Lespinet V, Bordone O, Lalvée S, Zahaf K, Poudenx M, Humbert O, Montaudié H, Dugourd PM, Chassang M, Passeron T, Delingette H, Marquette CH, Hofman V, Stenzinger A, Ilié M, Hofman P.

Cancers (Basel). 2019 Aug 29;11(9). pii: E1271. doi: 10.3390/cancers11091271.

8.

Alternative splicing of P2RX7 pre-messenger RNA in health and diseases: Myth or reality?

Benzaquen J, Heeke S, Janho Dit Hreich S, Douguet L, Marquette CH, Hofman P, Vouret-Craviari V.

Biomed J. 2019 Jun;42(3):141-154. doi: 10.1016/j.bj.2019.05.007. Epub 2019 Jul 15. Review.

9.

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids.

Alcala N, Leblay N, Gabriel AAG, Mangiante L, Hervas D, Giffon T, Sertier AS, Ferrari A, Derks J, Ghantous A, Delhomme TM, Chabrier A, Cuenin C, Abedi-Ardekani B, Boland A, Olaso R, Meyer V, Altmuller J, Le Calvez-Kelm F, Durand G, Voegele C, Boyault S, Moonen L, Lemaitre N, Lorimier P, Toffart AC, Soltermann A, Clement JH, Saenger J, Field JK, Brevet M, Blanc-Fournier C, Galateau-Salle F, Le Stang N, Russell PA, Wright G, Sozzi G, Pastorino U, Lacomme S, Vignaud JM, Hofman V, Hofman P, Brustugun OT, Lund-Iversen M, Thomas de Montpreville V, Muscarella LA, Graziano P, Popper H, Stojsic J, Deleuze JF, Herceg Z, Viari A, Nuernberg P, Pelosi G, Dingemans AMC, Milione M, Roz L, Brcic L, Volante M, Papotti MG, Caux C, Sandoval J, Hernandez-Vargas H, Brambilla E, Speel EJM, Girard N, Lantuejoul S, McKay JD, Foll M, Fernandez-Cuesta L.

Nat Commun. 2019 Aug 20;10(1):3407. doi: 10.1038/s41467-019-11276-9.

10.

The needle in the haystack: Histology of post-mortem computed tomography guided biopsies versus autopsy derived tissue.

Latten BGH, Bakers FCH, Hofman PAM, Zur Hausen A, Kubat B.

Forensic Sci Int. 2019 Jul 27;302:109882. doi: 10.1016/j.forsciint.2019.109882. [Epub ahead of print]

PMID:
31430676
11.

The molecular pathology of eye tumors: A 2019 update Main interests for routine clinical practice.

Nahon-Esteve S, Martel A, Maschi C, Caujolle JP, Baillif S, Lassalle S, Hofman P.

Curr Mol Med. 2019 Jul 26. doi: 10.2174/1566524019666190726161044. [Epub ahead of print]

PMID:
31418658
12.

The nuclear hypoxia-regulated NLUCAT1 long non-coding RNA contributes to an aggressive phenotype in lung adenocarcinoma through regulation of oxidative stress.

Moreno Leon L, Gautier M, Allan R, Ilié M, Nottet N, Pons N, Paquet A, Lebrigand K, Truchi M, Fassy J, Magnone V, Kinnebrew G, Radovich M, Cheok MH, Barbry P, Vassaux G, Marquette CH, Ponzio G, Ivan M, Pottier N, Hofman P, Mari B, Rezzonico R.

Oncogene. 2019 Aug 15. doi: 10.1038/s41388-019-0935-y. [Epub ahead of print]

PMID:
31417181
13.

Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment.

Heeke S, Mograbi B, Alix-Panabières C, Hofman P.

Cells. 2019 Jul 13;8(7). pii: E714. doi: 10.3390/cells8070714. Review.

14.

A pilot randomized controlled trial of a gratitude intervention for adolescents with Type 1 diabetes.

Schache KR, Hofman PL, Serlachius AS.

Diabet Med. 2019 Jul 17. doi: 10.1111/dme.14078. [Epub ahead of print]

PMID:
31315150
15.

Microstructural white matter changes preceding white matter hyperintensities in migraine.

Arkink EB, Palm-Meinders IH, Koppen H, Milles J, van Lew B, Launer LJ, Hofman PAM, Terwindt GM, van Buchem MA, Ferrari MD, Kruit MC.

Neurology. 2019 Aug 13;93(7):e688-e694. doi: 10.1212/WNL.0000000000007940. Epub 2019 Jul 11.

PMID:
31296653
16.

Post-mortem computed tomography in forensic investigations of lethal gunshot incidents: is there an added value?

van Kan RAT, Haest IIH, Lobbes MBI, Kroll J, Ernst SR, Kubat B, Hofman PAM.

Int J Legal Med. 2019 Jul 1. doi: 10.1007/s00414-019-02108-y. [Epub ahead of print]

PMID:
31263946
17.

[Pseudo-tumor lesions induced by infectious agents. Case no. 8].

Hofman P, Benzaquen J, Lassalle S, Diascorn Y, Cohen C.

Ann Pathol. 2019 Aug;39(4):277-279. doi: 10.1016/j.annpat.2019.04.005. Epub 2019 Jun 26. French. No abstract available.

PMID:
31255414
18.

[Pseudo-tumor lesions induced by infectious agents. Case no. 7].

Hofman P, Benzaquen J, Diascorn Y, Cohen C.

Ann Pathol. 2019 Aug;39(4):274-276. doi: 10.1016/j.annpat.2019.04.006. Epub 2019 Jun 26. French. No abstract available.

PMID:
31255413
19.

Toward precision medicine based on the molecular landscape of carcinoma in situ of the bronchus: is it realistic for patients with pre-invasive lung disease?

Hofman P.

J Thorac Dis. 2019 May;11(Suppl 9):S1286-S1288. doi: 10.21037/jtd.2019.04.87. No abstract available.

20.

Partial remission in type 1 diabetes and associated factors: Analysis based on the insulin dose-adjusted hemoglobin A1c in children and adolescents from a regional diabetes center, Auckland, New Zealand.

Chiavaroli V, Derraik JGB, Jalaludin MY, Albert BB, Ramkumar S, Cutfield WS, Hofman PL, Jefferies CA.

Pediatr Diabetes. 2019 Nov;20(7):892-900. doi: 10.1111/pedi.12881. Epub 2019 Jul 4.

PMID:
31237756
21.

Correction: Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.

Fumet JD, Richard C, Ledys F, Klopfenstein Q, Joubert P, Routy B, Truntzer C, Gagné A, Hamel MA, Guimaraes CF, Coudert B, Arnould L, Favier L, Lagrange A, Ladoire S, Saintigny P, Ortiz-Cuaran S, Perol M, Foucher P, Hofman P, Ilie M, Chevrier S, Boidot R, Derangere V, Ghiringhelli F.

Br J Cancer. 2019 Jul;121(3):283. doi: 10.1038/s41416-019-0512-8.

22.

Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients?

Hofman P, Heeke S, Alix-Panabières C, Pantel K.

Ann Oncol. 2019 Sep 1;30(9):1448-1459. doi: 10.1093/annonc/mdz196.

PMID:
31228184
23.

Compound heterozygosity for a frameshift mutation and an upstream deletion that reduces expression of SERPINH1 in siblings with a moderate form of osteogenesis imperfecta.

Schwarze U, Cundy T, Liu YJ, Hofman PL, Byers PH.

Am J Med Genet A. 2019 Aug;179(8):1466-1475. doi: 10.1002/ajmg.a.61170. Epub 2019 Jun 9.

PMID:
31179625
24.

The impact of demographic factors on newborn TSH levels and congenital hypothyroidism screening.

Heather NL, Derraik JGB, Webster D, Hofman PL.

Clin Endocrinol (Oxf). 2019 Sep;91(3):456-463. doi: 10.1111/cen.14044. Epub 2019 Jun 11.

PMID:
31162702
25.

Screening for brain metastases in patients with stage III non-small-cell lung cancer, magnetic resonance imaging or computed tomography? A prospective study.

Schoenmaekers J, Hofman P, Bootsma G, Westenend M, de Booij M, Schreurs W, Houben R, De Ruysscher D, Dingemans AM, Hendriks LEL.

Eur J Cancer. 2019 Jul;115:88-96. doi: 10.1016/j.ejca.2019.04.017. Epub 2019 May 23.

PMID:
31129385
26.

The importance of rurality data in understanding access to healthcare services for childhood obesity.

Wild CE, Grant CC, Cave TL, Wynter LE, Derraik JG, Willing EJ, Hofman PL, Anderson YC.

N Z Med J. 2019 May 3;132(1494):60-63. No abstract available.

PMID:
31048826
27.

Is the onset of adverse effects of immunotherapy always bad news for the patients…?-certainly not!

Hofman P.

Ann Transl Med. 2019 Mar;7(Suppl 1):S5. doi: 10.21037/atm.2019.01.14. No abstract available.

28.

Companion diagnostic tests for treatment of lung cancer patients: what are the current and future challenges?

Hofman P, Barlesi F.

Expert Rev Mol Diagn. 2019 May;19(5):429-438. doi: 10.1080/14737159.2019.1611426. Epub 2019 May 6.

PMID:
31018102
29.

[Pseudotumor lesions induced by infectious agents. Introduction].

Hofman P, Tauziède-Espariat A.

Ann Pathol. 2019 Aug;39(4):246-247. doi: 10.1016/j.annpat.2019.03.004. Epub 2019 Apr 16. French. No abstract available.

PMID:
31003708
30.

Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients.

Hofman V, Rouquette I, Long-Mira E, Piton N, Chamorey E, Heeke S, Vignaud JM, Yguel C, Mazières J, Lepage AL, Bibeau F, Begueret H, Lassalle S, Lalvée S, Zahaf K, Benzaquen J, Poudenx M, Marquette CH, Sabourin JC, Ilié M, Hofman P.

J Thorac Oncol. 2019 Jul;14(7):1204-1212. doi: 10.1016/j.jtho.2019.03.024. Epub 2019 Apr 15.

PMID:
30999109
31.

PD1/PD-L1 inhibitor treatment for late stage non-small cell lung carcinoma, sometimes…does more harm than good!

Hofman P.

J Thorac Dis. 2019 Mar;11(Suppl 3):S396-S398. doi: 10.21037/jtd.2018.11.140. No abstract available.

32.

Symptomatic Carotid Plaques Demonstrate Less Leaky Plaque Microvasculature Compared With the Contralateral Side: A Dynamic Contrast-Enhanced Magnetic Resonance Imaging Study.

Crombag GAJC, van Hoof RHM, Holtackers RJ, Schreuder FHBM, Truijman MTB, Schreuder TAHCML, van Orshoven NP, Mess WH, Hofman PAM, van Oostenbrugge RJ, Wildberger JE, Kooi ME.

J Am Heart Assoc. 2019 Apr 16;8(8):e011832. doi: 10.1161/JAHA.118.011832.

33.

The Long Noncoding RNA DNM3OS Is a Reservoir of FibromiRs with Major Functions in Lung Fibroblast Response to TGF-β and Pulmonary Fibrosis.

Savary G, Dewaeles E, Diazzi S, Buscot M, Nottet N, Fassy J, Courcot E, Henaoui IS, Lemaire J, Martis N, Van der Hauwaert C, Pons N, Magnone V, Leroy S, Hofman V, Plantier L, Lebrigand K, Paquet A, Lino Cardenas CL, Vassaux G, Hofman P, Günther A, Crestani B, Wallaert B, Rezzonico R, Brousseau T, Glowacki F, Bellusci S, Perrais M, Broly F, Barbry P, Marquette CH, Cauffiez C, Mari B, Pottier N.

Am J Respir Crit Care Med. 2019 Jul 15;200(2):184-198. doi: 10.1164/rccm.201807-1237OC.

PMID:
30964696
34.

Caregiver's readiness for change as a predictor of outcome and attendance in an intervention programme for children and adolescents with obesity: a secondary data analysis.

Anderson YC, Dolan GMS, Wynter LE, Treves KF, Wouldes TA, Grant CC, Cave TL, Smiley AJ, Derraik JGB, Cutfield WS, Hofman PL.

BMJ Open. 2019 Mar 27;9(3):e023195. doi: 10.1136/bmjopen-2018-023195.

35.

Are There New Biomarkers in Tissue and Liquid Biopsies for the Early Detection of Non-Small Cell Lung Cancer?

Calabrese F, Lunardi F, Pezzuto F, Fortarezza F, Vuljan SE, Marquette C, Hofman P.

J Clin Med. 2019 Mar 26;8(3). pii: E414. doi: 10.3390/jcm8030414. Review.

36.

DNAshell Protects DNA Stored at Room Temperature for Downstream Next-Generation Sequencing Studies.

Washetine K, Heeke S, Ribeyre C, Bourreau C, Normand C, Blons H, Laurent-Puig P, Mulot C, Clermont D, David M, Clément B, Dagher G, Hofman P.

Biopreserv Biobank. 2019 Aug;17(4):352-354. doi: 10.1089/bio.2018.0129. Epub 2019 Mar 26. No abstract available.

PMID:
30912674
37.

Is CT bulletproof? On the use of CT for characterization of bullets in forensic radiology.

Paulis LE, Kroll J, Heijnens L, Huijnen M, Gerretsen R, Backes WH, Hofman PAM.

Int J Legal Med. 2019 Mar 26. doi: 10.1007/s00414-019-02033-0. [Epub ahead of print]

PMID:
30911839
38.

Idiopathic short stature and growth hormone sensitivity in prepubertal children.

Derraik JGB, Miles HL, Chiavaroli V, Hofman PL, Cutfield WS.

Clin Endocrinol (Oxf). 2019 Jul;91(1):110-117. doi: 10.1111/cen.13976. Epub 2019 Apr 10.

PMID:
30908679
39.

Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications.

Blum Y, Meiller C, Quetel L, Elarouci N, Ayadi M, Tashtanbaeva D, Armenoult L, Montagne F, Tranchant R, Renier A, de Koning L, Copin MC, Hofman P, Hofman V, Porte H, Le Pimpec-Barthes F, Zucman-Rossi J, Jaurand MC, de Reyniès A, Jean D.

Nat Commun. 2019 Mar 22;10(1):1333. doi: 10.1038/s41467-019-09307-6.

40.

Recent advances in the molecular landscape of lung neuroendocrine tumors.

Pelosi G, Bianchi F, Hofman P, Pattini L, Ströbel P, Calabrese F, Naheed S, Holden C, Cave J, Bohnenberger H, Dinter H, Harari S, Albini A, Sonzogni A, Papotti M, Volante M, Ottensmeier CH.

Expert Rev Mol Diagn. 2019 Apr;19(4):281-297. doi: 10.1080/14737159.2019.1595593. Epub 2019 Mar 27.

PMID:
30900485
41.

[Tumor banks and complex data management: Current and future challenges].

Hofman P, Dagher G, Laurent-Puig P, Marquette CH, Barlesi F, Bibeau F, Clément B.

Ann Pathol. 2019 Apr;39(2):137-143. doi: 10.1016/j.annpat.2019.01.017. Epub 2019 Feb 25. French.

PMID:
30819623
42.

Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer-Just About Ready for Prime-Time?

Hofman P, Badoual C, Henderson F, Berland L, Hamila M, Long-Mira E, Lassalle S, Roussel H, Hofman V, Tartour E, Ilié M.

Cancers (Basel). 2019 Feb 27;11(3). pii: E283. doi: 10.3390/cancers11030283. Review.

43.

Circulating Tumor Cell Detection in Lung Cancer: But to What End?

Hofman V, Heeke S, Marquette CH, Ilié M, Hofman P.

Cancers (Basel). 2019 Feb 23;11(2). pii: E262. doi: 10.3390/cancers11020262. Review.

44.

The OncoAge Consortium: Linking Aging and Oncology from Bench to Bedside and Back Again.

Hofman P, Ayache N, Barbry P, Barlaud M, Bel A, Blancou P, Checler F, Chevillard S, Cristofari G, Demory M, Esnault V, Falandry C, Gilson E, Guérin O, Glaichenhaus N, Guigay J, Ilié M, Mari B, Marquette CH, Paquis-Flucklinger V, Prate F, Saintigny P, Seitz-Polsky B, Skhiri T, Van Obberghen-Schilling E, Van Obberghen E, Yvan-Charvet L.

Cancers (Basel). 2019 Feb 21;11(2). pii: E250. doi: 10.3390/cancers11020250.

45.

Do changes in weight status affect cognitive function in children and adolescents with obesity? A secondary analysis of a clinical trial.

Anderson YC, Kirkpatrick K, Dolan GMS, Wouldes TA, Grant CC, Cave TL, Wild CEK, Derraik JGB, Cutfield WS, Hofman PL.

BMJ Open. 2019 Feb 19;9(2):e021586. doi: 10.1136/bmjopen-2018-021586.

46.

Circulating free tumor DNA in non-small cell lung cancer (NSCLC): clinical application and future perspectives.

Herbreteau G, Vallée A, Charpentier S, Normanno N, Hofman P, Denis MG.

J Thorac Dis. 2019 Jan;11(Suppl 1):S113-S126. doi: 10.21037/jtd.2018.12.18. Review.

47.

Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors.

Berland L, Heeke S, Humbert O, Macocco A, Long-Mira E, Lassalle S, Lespinet-Fabre V, Lalvée S, Bordone O, Cohen C, Leroy S, Hofman V, Hofman P, Ilié M.

J Thorac Dis. 2019 Jan;11(Suppl 1):S71-S80. doi: 10.21037/jtd.2018.11.102. Review.

48.

Resistances to EGFR tyrosine kinase inhibitors in lung cancer-how to routinely track them in a molecular pathology laboratory?

Hofman V, Hofman P.

J Thorac Dis. 2019 Jan;11(Suppl 1):S65-S70. doi: 10.21037/jtd.2018.11.76. Review.

49.
50.

Advances in theranostic biomarkers for lung cancer from clinical to molecular pathology.

Hofman P.

J Thorac Dis. 2019 Jan;11(Suppl 1):S1-S2. doi: 10.21037/jtd.2018.10.28. No abstract available.

Supplemental Content

Loading ...
Support Center